lecture topics

  

Opening Ceremony

Immunity, immunopathology or autoimmunity: 
a question of what we know?

Rolf Zinkernagel, Switzerland

Basic

Tolerance and regulatory T cells and autoimmunity

Antonio Coutinho, Portugal

B cell selection: A physiological role for autoreactivity

B. David Stollar, USA

Fc gamma receptors and related autoantibodies in nonorgan-specific autoimmune diseases

Pierrre Youinou,France

Discrimination between self and nonself by the complement system

Seppo Meri, Finland

The role of epithelium in autoimmunity

H.M. Moutsopoulos, Greece

The immune neuro-endocrine basis of autoimmune diseases

Juan Josè Scali, Argentina

Regulatory T cells in autoimmune diseases: the role of non-Th1 cells. Basic Mechanisms and therapeutic perspectives

Jean-Francois Bach, France

Regulatory T cells preventing autoimmunity?
Peptides therapy in autoimmunity

Bevra Hahn, USA

Autoantibodies and the intracellular milieu. The why and the how

Donato Alarcon-Segovia, Mexico

Cell-cell contact, tissue destruction and autoimmunity

Jean-Michel Dayer, Switzerland

Environmental triggers of autoimmune disease

Noel Rose, USA

Cell-cell contact, cytokines and autoimmunity  Jean-Michel Dayer, Switzerland

The role of environmental antigens and mucosal immunity in development of autoimmunity

Helena Tlaskalova, Czech Republic

Effects of hsp60 on innate receptors in autoimmune disease

Irun R. Cohen, Israel

Reverse (or negative) acute phase protein in controlling autoimmunity

Jean-Michel Dayer, Switzerland

Molecular mimicry / degeneracy of T cell receptor recognition

Eli Sercarz, USA

S L E

SLE from target antigens to treatment

Joachim Kalden, Germany

Significance of prolactin in systemic lupus erythematosus and related diseases

Jozef Rovensky, Slovak Republic

The role of sFas in SLE

Ruud Smeenk, The Netherlands

Sex and Pregnancy

Sex and autoimmunity

Michael D. Lockshin, USA

Pregnancy and autoimmunity

Munther A. Khamashta, UK

Does autoimmune – reproductive failure have evolutionary implications?

Norbert Gleicher, USA

Autoimmunity and Pregnancy : APS and SLE - Cutting Edge

Angela Tincani, Italy

Influence of pregnancy on autoimmune thyroditis: the role of intrathyrodal microchimerism

Terry F. Davis, USA

Pregnancy and autoimmune thyroid disease (AITD)

Terry F. Davis, USA

Liver

Primary biliary cirrhosis: paradox versus paradigm for autoimmunity

M. Eric Gershwin, USA

A P S

Hughes Syndrome: a sideways look at the antiphospholipid syndrome

Graham Hughes, UK

Antiphospholipid antibodies; recent progress and future prospect

Takao Koike, Japan

Arthritis

Genes and environment in the development of arthritis

Lars Klareskog, Sweden

Resistance and susceptibility to autoimmune arthritis

Yaakov Naparstek, Israel

T cell dependent versus T cell independent pathways in the destruction of joints in RA

Steffen Gay, Switzerland

Vasculitis

New insights into the pathogenesis of ANCA - associated vasculitides

Cees G.M. Kallenberg, The Netherlands

Wegener's granulomatosis: a Th1 cytokine driven disease?

Wolfgang Gross, Germany

Autoantibodies associated with the vasculitic environment in necrotizing small vessel vasculitides

A. Wick, Denmark

Scleroderma

Role of T cell cytokines in the pathogenesis of scleroderma an autoimmune disease

Constantin A Bona, USA

Cellular and molecular aspects of the pathogenesis of scleroderma

Georg Wick, Austria

Thyroid diseases

The immunogenetics of autoimmune thyroid diseases

Yaron Tomer, USA

Diabetes Mellitus

Role of Insulin in pathogenesis / prediction / prevention

George Eisenbarth, USA

Atherosclerosis

Autoimmunity in the development of atherosclerosis

Georg Wick, Austria

Atherosclerosis; genomics, proteinomid and immunomics

James Peter, USA

Immunomodulation in atherosclerosis

Yehuda Shoenfeld, Israel

Rheumatic diseases, vasculitis and accelerated atherosclerosis

Paul A Bacon, UK

HDL / Apolipoprotein A-I in the control of autoimmune diseases

Jean-Michel Dayer, Switzerland

Ophthalmology

Bench to bedside: insights gained in the treatment of ocular disease

Robert Nussenblatt, USA

Experimental autoimmune encephalomyelitis - tracing effector T cells before and during clinical disease

Hartmut Wekerle, Germany

Cancer and Autoimmunity

Lymphoma in autoimmunity

H.M. Moutsopoulos, Greece

The predictive value of cancer associated autoantibodies

Karsten Conrad, Germany

Autoantibodies

Autoantibodies - I can measure them but what do they mean ?

Alan Tyndall, Switzerland

New targets for pathogenic autoantibodies

Stefano Bombardieri, Italy

Diagnostics

Analysis of global patterns of autoantibodies in health and disease (the antigen chip)

Irun R. Cohen, Israel

Vaccination and autoimmunity 

Vaccination inducing regulatory T cells to treat autoimmunity

Matthias Von Herrath, USA

Novel Therapies

Anti-inflammatory activity of statins

Pier Luigi Meroni, Italy

Stem cell therapy of autoimmune disease -
immunosuppression, immunoablation or immuno tinkering?

Alan Tyndall, Switzerland

IVIG - novel aspects in autoimmunity

Yehuda Shoenfeld, Israel

Antibody-based therapies for autoimmune diseases

Michael D. Kazatchkine, France

New frontiers in the treatment of autoimmune diseases

Guido Valesini, Italy

Specific peptide therapy of autoimmune disease

Irun R. Cohen, Israel

Peptide therapy in APS

Miri Blank, Israel

Successful approaches to multiple sclerosis therapy

Michael Sela, Israel

Gene transfer of protecting cytokines and signaling molecules -  Novel approaches for the treatment of rheumatoid arthritis

Steffen Gay, Switzerland

Modulation of cytokine function in autoimmune diseases

Ferry C. Breedveld, The Netherlands

TNF blockers for non-approved uses

Daniel Furst, USA

Novel aspects of oral tolerance

Howard Weiner, USA

Pathogenesis and novel aspects of RA

Joseph Smolen, Austria

 


Home | Welcome Note | Organizing Committee | Timetable
Lecture Topics | Suggested Topics | Scientific Program | General Information
Exhibition | Accompanying Persons' Program